Imiquimod applied topically: a novel immune response modifier and new class of drug (Q28140002)

1

0 references

J F Gerster

2

0 references

M L Owens

3

0 references

H B Slade

4

0 references

M A Tomai

International Journal of Immunopharmacology

5

0 references

language of work or name

English

0 references

publication date

January 1999

0 references

published in

0 references

volume

21

0 references

issue

1

0 references

page(s)

1-14

0 references

cites work

Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Treatment of genital warts with an immune-response modifier (imiquimod).

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Efficacy of S26308 against guinea pig cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Epidemiology of Genital Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Cytokine induction in mice by the immunomodulator imiquimod.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Imiquimod 5% cream (Aldara).

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Attenuation of virus-induced airway dysfunction in rats treated with imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Primary tissue culture of spontaneously regressing flat warts. In vitro attack by mononuclear cells against wart-derived epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Cytokine induction by the immunomodulators imiquimod and S-27609

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021

Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2898%2900068-X

7 January 2021